| |
 |
| |
| Our Focus |
 |
|
| |
Rapid urban development, changing lifestyles and an ageing society have all led
to changes in the ecology and demographics of
illness. In response to the resulting need for
interdisciplinary research, we strive to
 |
Provide leadership in health and medical research |
|
Coordinate expertise in the area of biomedical sciences through dedicated funding |
|
Promote interdisciplinary research initiatives in biomedical sciences |
|
Explore new frontiers in basic, clinical and applied research |
|
Transform research outcomes into clinical tests, treatments and products to directly
benefit patients |
|
| |
|
| |
| Our Edge |
|
|
| |
The University's strength in biomedical research pivots on
|
A team of eminent biological and medical experts who bring to CUHK exceptional scholarship, experience and dedication |
|
| Prominent research units of local and regional impact |
| — |
Li Ka Shing Institute of Health Sciences: strategically located at the Prince of Wales Hospital in one of the largest
clinical catchment areas within
the territory and with a broad
clinical base for translational
research in non-invasive diagnostics
and innovative therapeutics of
prevalent diseases |
| — |
School of Public Health: the first of its kind in Hong Kong and an important vehicle synergizing clinical
and socio-economic perspectives
in health issues ranging from
infectious and lifestyle-related
diseases to public health policies |
| — |
Institute of Chinese Medicine: recognized locally as an Area of Excellence (AoE) by the University Grants Committee (UGC) and worldwide by the US National Institutes of Health (NIH) as the first Hong Kong recipient of its Traditional Chinese Medicine grant |
| — |
Institute
of Plant Molecular Biology and
Agricultural Biotechnology: the
first science area to be designated
an AoE by the UGC; with 13 patents
filed and over 100 publications
in high-impact international
journals
|
| — |
State Key Laboratory in Oncology in South China (CUHK): the only national-level
research centre in Hong Kong
specializing in
cancers common in Asia, established
with the approval
of the Ministry of Science and Technology
of China |
|
|
| |
|
| |
| Our Achievements |
|
|
| |
Our success in the biomedical sciences is manifested through
|
| Publications |
| — |
Prolific publications in top academic journals, including the New England Journal of Medicine, Nature Medicine, Lancet and Science |
| — |
Contribution to 9 out of the 17 most cited papers in Clinical Medicine from Hong
Kong (Essential Science Indicators,
Institute of Scientific Information) |
|
|
| Products and Technologies |
| — |
Translation of research findings particularly on gastroenterology and molecular diagnostics into applied solutions that profoundly impact on medical practice |
| — |
Patents of newly discovered cancer biomarkers, DNA technology for disease detection and enhanced formulae for herbal and plant products |
|
|
| External Links |
| — |
Partnerships with leading universities and research organizations worldwide |
| — |
The only local university to be involved with NIH as a research partner |
|
|
| |
|
| |
| Some of Our Partners |
|
|
| |
|
| |
|
| |
| Themes under Major Area |
|
|
| |
|
Gastrointestinal Diseases |
|
Molecular Diagnostics |
|
Cancer Research |
|
Vascular Medicine |
|
Diabetes |
|
Public Health |
|
Epithelial Cell Biology |
|
Regenerative Medicine |
|
Traditional Chinese Medicine |
|
Plant Molecular Biology and Agricultural Biotechnology |
|
| |
|
| |
| Our Strategy for the Next Decade |
|
|
| |
We will embark on our quest to improve life and health by
|
Aligning research activities within CUHK and strengthening collaboration with
other prominent institutions in China
and overseas |
|
Focusing resources on thematic areas selected for their strength, community
relevance and stakeholder interest |
|
Fine-tuning existing expertise and recruiting new talents |
|
Enhancing research infrastructure in proteomics, bioinformatics and genomics |
|
| |
|
| |
| How We Can Contribute |
|
|
| |
We seek to advance human health in South China and Asia through
|
Bringing breakthroughs in diagnostics and prevention strategies for Asia's prevalent
diseases, including cancers, diabetes,
hypertension, genetic and chromosomal
diseases, HIV/AIDS, vascular and liver
diseases from bench-top to bedside |
|
Development of pharmaceutical products for treatment of common diseases |
|
Public education on lifestyle-related diseases and urban health issues |
|
Public policy research and consultancy services to governments and non-government organizations |
|
Providing solutions to problems of malnutrition and food shortage through biotechnological
innovations |
|
| |
|
| |
| Investing in Our Future |
|
|
| |
To deliver our promises in the next decade, we need, on top of university investment,
substantial funding support for
|
Start-up funding for new infrastructure and facilities |
|
Recruitment of dedicated research and management staff |
|
Endowment fund to sustain core functions in the longer term |
|
| |
|
| |
Who to Contact
Prof. Y.M. Dennis Lo
Faculty of Medicine
The Chinese University of Hong Kong
Department of Chemical Pathology
Prince of Wales Hospital
Shatin, NT, Hong Kong SAR
The People's Republic of China
Email: loym@cuhk.edu.hk
Telephone: (852) 2632 2963
Fax: (852) 2636 5090 |
 |
 |
|
| |
|